UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 306

Sortiert nach

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Mayo Clinic proceedings, 2019-08, Vol.94 (8), p.1623-1640

2019

Volltextzugriff (PDF)

Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors

The American journal of cardiology, 2020-06, Vol.125 (12), p.1920-1926

2020

Volltextzugriff (PDF)

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Mayo Clinic proceedings, 2008-05, Vol.83 (5), p.584-594

2008

Volltextzugriff (PDF)

Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells

PloS one, 2016-09, Vol.11 (9), p.e0162925

2016

Volltextzugriff (PDF)

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

The lancet oncology, 2010-10, Vol.11 (10), p.962-972

2010

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2139-2146

2008

Volltextzugriff (PDF)

Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges

Cancers, 2021-12, Vol.14 (1), p.109

2021

Volltextzugriff (PDF)

EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma

Cancers, 2023-04, Vol.15 (8), p.2274

2023

Volltextzugriff (PDF)

A genetic cell context-dependent role for ZEB1 in lung cancer

Nature communications, 2016-07, Vol.7 (1), p.12231-12231, Article 12231

2016

Volltextzugriff (PDF)

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

Frontiers in oncology, 2022-08, Vol.12, p.955440-955440

2022

Volltextzugriff (PDF)

Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)

Clinical lung cancer, 2012-07, Vol.13 (4), p.252-266

2012

Volltextzugriff (PDF)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

Cell death & disease, 2019-09, Vol.10 (10), p.725-16, Article 725

2019

Volltextzugriff (PDF)

Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)

JNCI : Journal of the National Cancer Institute, 2018-07, Vol.110 (7), p.734-742

2018

Volltextzugriff (PDF)

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.3179-3184

2012

Volltextzugriff (PDF)

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

The oncologist (Dayton, Ohio), 2019-01, Vol.24 (1), p.96-102

2019

Volltextzugriff (PDF)

The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2′-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells

The Journal of biological chemistry, 2015-07, Vol.290 (30), p.18480-18494

2015

Volltextzugriff (PDF)

Advances in Chemotherapy of Non-small Cell Lung Cancer

Chest, 2006-10, Vol.130 (4), p.1211-1219

2006

Volltextzugriff (PDF)

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Clinical cancer research, 2007-10, Vol.13 (19), p.5834-5840

2007

Volltextzugriff (PDF)

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells

Molecular oncology, 2015-01, Vol.9 (1), p.270-281

2015

Volltextzugriff (PDF)

Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors

Human pathology, 2019-12, Vol.94, p.78-85

2019

Volltextzugriff (PDF)

Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy

Thyroid (New York, N.Y.), 2011-01, Vol.21 (1), p.25

2011

Volltextzugriff (PDF)

Management of Multifocal Lung Cancer: Results of a Survey

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1398-1402

2017

Volltextzugriff (PDF)

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

Journal of clinical oncology, 2010-02, Vol.28 (4), p.614-619

2010

Volltextzugriff (PDF)

Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis

Journal of human genetics, 2014-03, Vol.59 (3), p.124-128

2014

Volltextzugriff (PDF)

Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis

Cancer cell, 2005, Vol.7 (1), p.39-49

2005

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(294)
Mit Volltextzugriff
(288)

Publikationsform

Sprache

Englisch
(305)
Japanisch
(42)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(196)
Life Sciences & Biomedicine
(149)
Humans
(126)
Male
(82)
Female
(74)
Oncology
(68)
Middle Aged
(62)
Aged
(56)
Adult
(46)
Technology
(41)
Computer Science
(37)
Computer Science, Theory & Methods
(37)
Biological And Medical Sciences
(36)
Computer Science, Artificial Intelligence
(36)
Computer Science, Information Systems
(35)
Medical Sciences
(31)
Lung Cancer
(28)
Tumors
(28)
Animals
(27)
Aged, 80 And Over
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges

EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma

A genetic cell context-dependent role for ZEB1 in lung cancer

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2′-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells

Advances in Chemotherapy of Non-small Cell Lung Cancer

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells

Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors

Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy

Management of Multifocal Lung Cancer: Results of a Survey

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis

Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis

Suchergebnisse filtern